Amicogen's growth engine starts with R&D. We continue innovative research and technology development for the first and best products.
Contribute to global environment and health
of mankind by developing world class bio products.
Grow as a global bio company by 2030 through innovative biotechnology development and commercialization
Amicogen, Inc. Overview
Global Bio Company
Amicogen has equipped with a strategic business structure in 3 business divisions,
'Enzyme · Bio pharmaceuticals’, 'health care' and 'bioprocess/ CDMO by combining sustainable enzyme technology and its applied technology.
Innovative, Enzyme platform
As a global bio leader beyond Korea, we remind our mission to
contribute to global environment and health of mankind by developing world class bio products' and lead the global environment and the sustainability of humankind.
KOSDAQ listing Since the KOSDAQ listing, Amicogen has introduced domestic and overseas technologies for synergy of our technologies and businesses by expanding R&D investment internally and by open innovation activities externally.
Bio-Works Technologies AB
Amicogen China Biopharm Co,.Ltd
Sandong Amicogen Biotechnology, LLC
Amicogen has developed a special enzyme, an eco-friendly biocatalyst, that replaces existing chemical catalysts using our own gene evolution technology. Our technology is specialized in the development of special enzymes used in the pharmaceutical, chemical and energy industries, which is evaluated as a future growth technology to replace chemical processes. Amicogen's original business, the special enzyme business, uses enzymes to produce the pharmaceutical raw material (API), intermediates for pharmaceuticals, biological pesticides, and food/cosmetics/feed additives, and promotes gradually expanding its area to enzyme drugs.
Gene evolution refers to a technology that artificially accelerates the recombination phenomenon that occurs in nature in vitro to select genes with the desired characteristics in a short period of time.
The yield and quality of reaction products can be increased by an efficient process
Mass production technology for enzymes and proteins
High value-added enzymes and proteins should be produced at a lower cost to replace the existing chemical process.
Immobilized enzyme development and mass production technology
In order to use expensive enzymes and proteins industrially, these materials should be reused as much as possible in the production process to reduce cost and further increase competitiveness compared to chemical processes.